The Illumina Genomics Forum is Illumina’s premier global event advancing the positive impact of genomic health. G2P Director Dr. Robert Green spoke alongside Ryan Taft on building the evidence base for offering comprehensive sequencing for every child at birth.
At the inaugural International Conference on Newborn Sequencing, researchers from eight studies across the world outlined their plans, goals, and results to date for their newborn sequencing initiatives. The BabySeq Project led by Robert Green at Brigham and Women’s Hospital, the Broad Institute and Harvard Medical School was the first randomized clinical trial designed to … Continued
PMWC, the “Precision Medicine World Conference” is the largest & original annual conference dedicated to precision medicine. At this year’s PMWC, G2P director Dr. Robert C. Green gave a talk on the path to universal newborn sequencing and disease prevention.
Through the Achieving Research Equity & Inclusion Conference, Mass General Brigham engages stakeholders from across the country and our communities for a unique opportunity to change how we do research. Click the link below to hear Dr. Robert C. Green talk about medical research in genomics, where theory meets practice.
Hear from a panel of experts, including Dr. Robert C. Green, about the challenges and opportunities ahead for genomics and precision health, as well as how researchers, clinicians and other stakeholders are working to make sure that such efforts are inclusive, equitable, accessible and effective.
In this debate hosted by the University of Chicago School of Medicine, Dr. Lainie Ross and Dr. Robert C. Green both respond to the question “should all newborns have their genomes sequenced at birth?”
Dr. Robert C. Green presents at the World Medical Innovation Forum on “Newborn Sequencing and Prevention of Rare Diseases: A New Public Health and Biopharma Challenge.”
On April 5th, 2022, initiatives from around the globe will virtually convene for a meeting of the Genomics in Health Implementation Forum (GHIF). This focused workshop aims to share the status of international efforts establishing genomic newborn screening programs and identify areas for engagement with GA4GH Work Streams.
Dr. Robert C. Green at the 2021 Magee-Womens Summit: The Path to Preventive Genomics.
Meet two innovative collaborators using the power of DNA to transform medicine and prevent disease. Francesco Carrozzini, filmmaker, will share his story and inspiration for the Fund dedicated to his mother and late editor for Vogue Italia, Franca Sozzani. Dr. Robert Green, professor of medicine, will present scientific evidence supporting preventive genomics. Attendees will also hear about … Continued
What Happens Next examines the future as we confront massive technological transformations in central aspects of daily life. In this video, G2P’s Dr. Robert Green shares what we’ve learned from genetic testing in healthy individuals over the past decade.
Dr. Robert Green presents at the 2021 Genomic Life Conference on “Genomic Medicine Today and the Path to Prevention.”
This free 3 day NIH sponsored conference brings academia, industry, and government together to accelerate access to gene-targeted therapies. G2P’s Dr. Robert Green co-chairs the planning committee and will be one of the speakers opening the conference on June 3 as well as speaking about BabySeq on June 10.
Augustana University and the Center for Western Studies hosted the 24th Boe Forum on Public Affairs on Monday, March 15th. This virtual event featured keynote speakers Dr. Robert Green and Dr. Jamie Metzl.
Following a screening of the NOVA documentary, “Secrets in our DNA,” the Computer History Museum hosted a panel with science and business experts about personal genetic testing. Click the link below to hear contributions by G2P director Dr. Green.
In this NOVA documentary, G2P director Dr. Green explains what DNA can reveal about our ancestry and health, and at what risk.
Dr. Robert C. Green gives talk at the December 2020 Meeting of the Advisory Committee on Heritable Disorders in Newborns and Children on “Newborn Sequencing in Genomic Medicine and Public Health (NSIGHT).”
In this talk for the National Hellenic Society, Dr. Robert Green, MD, MPH and Bethany Zettler, MS, CGC discuss the genetics of COVID vulnerability and how Genomes2People’s work has pivoted to support COVID-19 research during this pandemic.
With expert Robert Green, M.D., MPH, facilitated by Ronnie Stangler, M.D. In this presentation, Dr. Green will review exciting new findings in genomics that are revolutionizing medical care across multiple disciplines, preventing illness and extending healthy lifespan.
In the first of a two-part series, AMA Chief Experience Officer Todd Unger discusses genetics at play in COVID-19 with experts Wendy Chung, MD, PhD, Robert Green, MD, MPH, and AMA’s Chief Health and Science Officer Mira Irons, MD.
Boston researchers using COVID-19 patients’ DNA to unlock secrets about impact of virus
Meet BabySeq participants, Cora and her mom. Through our NIH-funded BabySeq Project, Cora was diagnosed with partial biotinidase deficiency, which was missed on her traditional newborn screening test. Listen to their story.
Meet Tom, a Partners HealthCare Biobank Research Participant, who was discovered to have a genetic variation for Fabry Disease. Checkout his story to understand his genes, the impacts on his healthcare and family.
Meet Brian, who through the Partners HealthCare Biobank learned that he was a carrier for familial adenomatous polyposis (FAP). Watch to learn about his journey!
Meet Chris, a Partners HealthCare Biobank research participant who learned about her risk for developing breast cancer. Listen to her story.
Dr. Robert Green is the director of the Preventive Genomics Clinic at Brigham and Women’s Hospital in Boston. He believes that DNA testing combined with proper counseling and medical follow-up would be a critical element of a healthcare system that can prevent illness.
Dr. Robert C. Green presents at the Medical and Population Genetics Conference at the Broad Institute.
At a new clinic in Boston, genetic counselor Carrie Blout helps healthy patients get their DNA tested for predispositions to more than 2500 diseases. Bloomberg’s Aki Ito goes through the testing herself, trialing a controversial technology at the forefront of modern medicine.
Dr. Robert C. Green presents on the case for preventive genomics: BabySeq at the 2019 NSIGHT Steering Committee Meeting.
Preventive Genomics Now! Robert Green M.D., MPH, Professor of Medicine (Genetics) Director, Genomes2People Research Program, Brigham and Women’s Hospital, Broad Institute, at 21st Future of Health Technology Summit at MIT Bartos Theatre produced by Renata Bushko Founder Future of Health Technology Institute FHTI since 1995.
Researchers analyzed nearly 5,000 genes looking for the risk of diseases and found that almost 10 percent of babies tested were at risk for a condition that could be treated early.
Dr. Robert C. Green speaks at the 2018 Advances in Genome Biology and Technology (AGBT) Precision Health Conference in San Diego, California about our efforts to gather empirical data on genome sequencing healthy individuals. Watch to learn more about G2P’s MilSeq, BabySeq, MedSeq, PeopleSeq, PGen and REVEAL projects. Click here for more on the conference.
Our very own Dr. Robert Green along with other genomic experts discuss “Deep Dive: Genetics and Genomics, Today and Tomorrow” explaining how genomics is changing much of what we know about medicine and what we can expect in the future at the Aspen Ideas Festival 2018. Additionally, Dr. Green presents “Med School: Separating Hype from Hope … Continued
Follow new parents Katherine and Jason as they meet with Genomes2People Genetic Counselors to learn about their baby boy’s genome sequencing results as part of our BabySeq Project.
Dr. Robert C. Green talks about The BabySeq Project, the world’s first study of genetically sequencing newborns, and how genetic information can influence one’s medical care beginning from birth.
Genomic testing for Baby Cora, a participant of The BabySeq Project, revealed a disorder that might otherwise have gone undetected until life-long health issues presented themselves.
Gaining information by getting your DNA sequenced on what diseases you have risks for and can take preventative measures based on this information
Our Genomes2People research program focuses on rigorously measuring clinical utility and how to translate new advances in genomic medicine into the best outcomes for patients and families. By navigating this “last mile” of medical genomics, we can help understand how to change the marvelous discoveries of big data studies into real benefits for real people. … Continued
Megan Tirrell seeks out Dr. Robert Green to have her genome sequenced and discusses her experience through the entire process; from meetings with the genetic counselors and learning about cost and variants of unknown significance, to getting her results in her disclosure meetings.
